NTRK1 and neoplasm: Alternative NTRK1/TrkA splicing, resulting in expression of the TrkAIII splice variant (GeneBank OP866787), represents a potential oncogenic alternative to Trk-fused genes in different tumor types [16,17,18,19,20,21,22,23,24].